Skip to main content
. 2009 Jun 11;27(34):4630–4640. doi: 10.1016/j.vaccine.2009.05.072

Table 1.

Results of the pathogenicity study using four IBV strains.

Groupa Dose, median embryo infectious doses (log 10)b Morbidity (%) Mortality (%) Virus recoveryc
Antibody (%)d
4e 8 12 16 20 4e 8 12 16 20
CK/CH/LHLJ/04Vf 4.8 100 40 + + + 0/9(0) 6/7(86) 6/6(100) 6/6(100) 6/6(100)
CK/CH/LDL/04II 4.7 100 30 + + + 0/9(0) 7/7(100) 7/7(100) 7/7(100) 7/7(100)
CK/CH/LXJ/02I 4.8 100 20 + + 3/10(30) 8/8(100) 8/8(100) 8/8(100) 8/8(100)
CK/CH/LSHH/03I 4.8 100 20 + 0/10(0) 8/8(100) 8/8(100) 8/8(100) 8/8(100)
Control 0 0 0/10(0) 0/10(0) 0/10(0) 0/10(0) 0/10(0)
a

Ten chicks per group.

b

Dose per chick, 100 μL.

c

Two procedures were used for virus recovery after challenge. First, lesions in embryos that had been inoculated with pooled samples (tracheal swabs) were observed. Second, RT-PCR using oligonucleotide primers N(+) and N(−) on RNA recovered from allantoic fluid of the same eggs was conducted. The results from the two procedures were identical.

d

Number seroconverted/number inoculated.

e

Days after challenge.

f

CK/CH/LHLJ/04V passage 3 (P3) was used for the virulence study.